Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-14
DOI
10.1111/jcmm.16548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation
- (2020) Mei-Chun Chen et al. Cells
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain
- (2019) Robert G Ungard et al. Molecular Pain
- Sulfasalazine may modulate the CD 44v9‐ xCT system and enhance CDDP ‐induced cytotoxic effects in metastatic bladder cancer
- (2019) Koichiro Ogihara et al. CANCER SCIENCE
- Burden of Gastric Cancer
- (2019) Aaron P. Thrift et al. Clinical Gastroenterology and Hepatology
- The Xc− inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism
- (2019) Zijie Zheng et al. CELLULAR ONCOLOGY
- CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
- (2018) Eun Hye Kim et al. CANCER LETTERS
- High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: potential targets by sulfasalazine
- (2018) Fumitaka Wada et al. CANCER SCIENCE
- Clinical tools for chemotherapy toxicity prediction and survival in geriatric cancer patients
- (2018) Ioannis A. Voutsadakis JOURNAL OF CHEMOTHERAPY
- Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response
- (2018) Carlos Gustavo Garcia et al. MOLECULAR NEUROBIOLOGY
- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Biomarkers of gastric cancer: Current topics and future perspective
- (2018) Tasuku Matsuoka et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gastric cancer: epidemiology, prevention, classification, and treatment
- (2018) Robert Sitarz et al. Cancer Management and Research
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effects of Various Pharmaceutical Excipients on the Intestinal Transport and Absorption of Sulfasalazine, a Typical Substrate of Breast Cancer Resistance Protein Transporter
- (2018) Kasirawat Sawangrat et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- CD44v-dependent upregulation of xCT is involved in the acquisition of cisplatin-resistance in human lung cancer A549 cells
- (2018) Sayo Horibe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis
- (2018) Sheng-Fan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
- (2018) Seung-Shick Shin et al. Oncogenesis
- Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
- (2017) Z Fan et al. Oncogenesis
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started